NATCO PHARMA LTD.

NSE : NATCOPHARMBSE : 524816ISIN CODE : INE987B01026Industry : Pharmaceuticals & DrugsHouse : Natco
BSE1008.85-13.2 (-1.29 %)
PREV CLOSE ( ) 1022.05
OPEN PRICE ( ) 1029.00
BID PRICE (QTY) 1008.00 (1)
OFFER PRICE (QTY) 1008.85 (1)
VOLUME 4264
TODAY'S LOW / HIGH ( )1008.00 1029.75
52 WK LOW / HIGH ( )560.15 1107.85
NSE1008.60-14.2 (-1.39 %)
PREV CLOSE( ) 1022.80
OPEN PRICE ( ) 1028.00
BID PRICE (QTY) 1008.50 (52)
OFFER PRICE (QTY) 1008.95 (106)
VOLUME 169101
TODAY'S LOW / HIGH( ) 1007.70 1031.00
52 WK LOW / HIGH ( )563 1108.35

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.